These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

611 related items for PubMed ID: 17933712

  • 21. Angiotensin II type 1 receptor expression is increased via 12-lipoxygenase in high glucose-stimulated glomerular cells and type 2 diabetic glomeruli.
    Xu ZG, Miao LN, Cui YC, Jia Y, Yuan H, Wu M.
    Nephrol Dial Transplant; 2009 Jun; 24(6):1744-52. PubMed ID: 19103735
    [Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26. Peroxisome proliferator activated receptor alpha/gamma dual agonist tesaglitazar attenuates diabetic nephropathy in db/db mice.
    Cha DR, Zhang X, Zhang Y, Wu J, Su D, Han JY, Fang X, Yu B, Breyer MD, Guan Y.
    Diabetes; 2007 Aug; 56(8):2036-45. PubMed ID: 17536062
    [Abstract] [Full Text] [Related]

  • 27. Effects of eicosapentaenoic acid on the early stage of type 2 diabetic nephropathy in KKA(y)/Ta mice: involvement of anti-inflammation and antioxidative stress.
    Zhang M, Hagiwara S, Matsumoto M, Gu L, Tanimoto M, Nakamura S, Kaneko S, Gohda T, Qian J, Horikoshi S, Tomino Y.
    Metabolism; 2006 Dec; 55(12):1590-8. PubMed ID: 17142129
    [Abstract] [Full Text] [Related]

  • 28. Spironolactone exhibits direct renoprotective effects and inhibits renal renin-angiotensin-aldosterone system in diabetic rats.
    Taira M, Toba H, Murakami M, Iga I, Serizawa R, Murata S, Kobara M, Nakata T.
    Eur J Pharmacol; 2008 Jul 28; 589(1-3):264-71. PubMed ID: 18582458
    [Abstract] [Full Text] [Related]

  • 29. Increased urinary type IV collagen marks the development of glomerular pathology in diabetic d/db mice.
    Cohen MP, Lautenslager GT, Shearman CW.
    Metabolism; 2001 Dec 28; 50(12):1435-40. PubMed ID: 11735089
    [Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32. [The early pathological changes of KKAy mice with type 2 diabetes].
    Chen LM, Li XW, Huang LW, Li Y, Duan L, Zhang XJ.
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2002 Feb 28; 24(1):71-5. PubMed ID: 12905844
    [Abstract] [Full Text] [Related]

  • 33. Protective effect of a poly-phytocompound on early stage nephropathy secondary to experimentally-induced diabetes.
    Marotta F, Harada M, Dallah ED, Yadav H, Solimene U, Di Lembo S, Minelli E, Jain S, Chui DH.
    J Biol Regul Homeost Agents; 2010 Feb 28; 24(1):41-9. PubMed ID: 20385070
    [Abstract] [Full Text] [Related]

  • 34. Thrombospondin-1 is an endogenous activator of TGF-beta in experimental diabetic nephropathy in vivo.
    Daniel C, Schaub K, Amann K, Lawler J, Hugo C.
    Diabetes; 2007 Dec 28; 56(12):2982-9. PubMed ID: 17878288
    [Abstract] [Full Text] [Related]

  • 35. SMP-534 ameliorates progression of glomerular fibrosis and urinary albumin in diabetic db/db mice.
    Sugaru E, Nakagawa T, Ono-Kishino M, Nagamine J, Tokunaga T, Kitoh M, Hume WE, Nagata R, Taiji M.
    Am J Physiol Renal Physiol; 2006 Apr 28; 290(4):F813-20. PubMed ID: 16278277
    [Abstract] [Full Text] [Related]

  • 36. Lessons learned from studies of the natural history of diabetic nephropathy in young type 1 diabetic patients.
    Steinke JM, Mauer M, International Diabetic Nephropathy Study Group.
    Pediatr Endocrinol Rev; 2008 Aug 28; 5 Suppl 4():958-63. PubMed ID: 18806710
    [Abstract] [Full Text] [Related]

  • 37. Lack of {alpha}8-integrin aggravates podocyte injury in experimental diabetic nephropathy.
    Hartner A, Cordasic N, Menendez-Castro C, Volkert G, Yabu JM, Kupraszewicz-Hutzler M, Rascher W, Hilgers KF.
    Am J Physiol Renal Physiol; 2010 Nov 28; 299(5):F1151-7. PubMed ID: 20826576
    [Abstract] [Full Text] [Related]

  • 38. Regular moderate exercise reduces advanced glycation and ameliorates early diabetic nephropathy in obese Zucker rats.
    Boor P, Celec P, Behuliak M, Grancic P, Kebis A, Kukan M, Pronayová N, Liptaj T, Ostendorf T, Sebeková K.
    Metabolism; 2009 Nov 28; 58(11):1669-77. PubMed ID: 19608208
    [Abstract] [Full Text] [Related]

  • 39. Renal fibrosis and glomerulosclerosis in a new mouse model of diabetic nephropathy and its regression by bone morphogenic protein-7 and advanced glycation end product inhibitors.
    Sugimoto H, Grahovac G, Zeisberg M, Kalluri R.
    Diabetes; 2007 Jul 28; 56(7):1825-33. PubMed ID: 17456853
    [Abstract] [Full Text] [Related]

  • 40. Connective tissue growth factor in tubulointerstitial injury of diabetic nephropathy.
    Wang S, Denichilo M, Brubaker C, Hirschberg R.
    Kidney Int; 2001 Jul 28; 60(1):96-105. PubMed ID: 11422741
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 31.